Xingyu Lin
1 Xinmin Street
Changchun, 130021, China
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Ancient Mycobacterium leprae genomes reveal a potential origin and dispersal of the ancestral Branch 0.
Journal: Communications biology
Published: December 11, 2025
Efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy in potentially resectable stage IIIA/IIIB non-small cell lung cancer: Neo-Pre-IC, a single-arm phase 2 trial.
Journal: EClinicalMedicine
Published: October 10, 2023
Synergistic effect of adavosertib and fimepinostat on acute myeloid leukemia cells by enhancing the induction of DNA damage.
Journal: Investigational new drugs
Published: September 28, 2023
Retraction notice to "Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis" [Biomed. Pharmacother. 124 (2020) 109858].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 02, 2023
Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer.
Journal: Frontiers in oncology
Published: May 25, 2022
Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial.
Journal: Journal of cancer research and clinical oncology
Published: September 09, 2021
Asynchrony of primary tumor and mediastinal lymph nodes response after neoadjuvant immunotherapy plus chemotherapy in a patient with stage IIIA non-small-cell lung cancer: a case report.
Journal: Anti-cancer drugs
Published: August 22, 2021
miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2.
Journal: Oncology letters
Published: June 30, 2021
Erratum: MiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2.
Journal: American journal of cancer research
Published: May 31, 2021
Interferon regulatory factor 6 correlates with the progression of non-small cell lung cancer and can be regulated by miR-320.
Journal: The Journal of pharmacy and pharmacology
Published: August 10, 2020
RETRACTED: Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 07, 2019
Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p.
Journal: Bioscience reports
Published: February 04, 2019
Last Updated: 09/26/2026